These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24392978)

  • 41. Adaptive methods: when and how should they be used in clinical trials?
    Porcher R; Lecocq B; Vray M;
    Therapie; 2011; 66(4):319-26, 309-17. PubMed ID: 21851793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interpreting and reporting clinical trials with results of borderline significance.
    Hackshaw A; Kirkwood A
    BMJ; 2011 Jul; 343():d3340. PubMed ID: 21727163
    [No Abstract]   [Full Text] [Related]  

  • 43. Interpretation of clinical trial results.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S114-20. PubMed ID: 19007606
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Statistical inference for clinical trials with binary responses when there is a shift in patient population.
    Yang LY; Chi Y; Chow SC
    J Biopharm Stat; 2011 May; 21(3):437-52. PubMed ID: 21442518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Minimize the use of minimization with unequal allocation.
    Proschan M; Brittain E; Kammerman L
    Biometrics; 2011 Sep; 67(3):1135-41. PubMed ID: 21281276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Statistical Controversies in Reporting of Clinical Trials: Part 2 of a 4-Part Series on Statistics for Clinical Trials.
    Pocock SJ; McMurray JJV; Collier TJ
    J Am Coll Cardiol; 2015 Dec; 66(23):2648-2662. PubMed ID: 26670066
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design and analytic concepts for periodontal clinical trials.
    Imrey PB; Chilton NW
    J Periodontol; 1992 Dec; 63(12 Suppl):1124-40. PubMed ID: 1479532
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Baseline observation carry forward: reasoning, properties, and practical issues.
    Shao J; Jordan DC; Pritchett YL
    J Biopharm Stat; 2009 Jul; 19(4):672-84. PubMed ID: 20183433
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primer: the fallacy of subgroup analysis.
    Guillemin F
    Nat Clin Pract Rheumatol; 2007 Jul; 3(7):407-13. PubMed ID: 17599075
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect sizes: the clinical relevance of study findings].
    Stulz N
    Psychother Psychosom Med Psychol; 2012 Jul; 62(7):288-9. PubMed ID: 22777907
    [No Abstract]   [Full Text] [Related]  

  • 51. On sample size determination in multi-armed confirmatory adaptive designs.
    Wassmer G
    J Biopharm Stat; 2011 Jul; 21(4):802-17. PubMed ID: 21516570
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Group sequential t-test for clinical trials with small sample sizes across stages.
    Shao J; Feng H
    Contemp Clin Trials; 2007 Sep; 28(5):563-71. PubMed ID: 17434814
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Strategies for identifying predictive biomarkers and subgroups with enhanced treatment effect in clinical trials using SIDES.
    Lipkovich I; Dmitrienko A
    J Biopharm Stat; 2014; 24(1):130-53. PubMed ID: 24392982
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adaptive designs for confirmatory clinical trials with subgroup selection.
    Stallard N; Hamborg T; Parsons N; Friede T
    J Biopharm Stat; 2014; 24(1):168-87. PubMed ID: 24392984
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Basic concepts in statistics for veterinary ophthalmologists.
    Montiani-Ferreira F; Cardoso FF; Petersen-Jones S
    Vet Ophthalmol; 2004; 7(2):79-85. PubMed ID: 14982586
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Critical reading of clinical trials].
    Aptel F; Cucherat M; Blumen-Ohana E; Denis P
    J Fr Ophtalmol; 2011 Dec; 34(10):755-61. PubMed ID: 21992992
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bayesian assessment of the influence and interaction conditions in multipopulation tailoring clinical trials.
    Millen BA; Dmitrienko A; Song G
    J Biopharm Stat; 2014; 24(1):94-109. PubMed ID: 24392980
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Statistical considerations for the next generation of clinical trials.
    Wu W; Shi Q; Sargent DJ
    Semin Oncol; 2011 Aug; 38(4):598-604. PubMed ID: 21810519
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Understanding the biology of sex and gender differences: using subgroup analysis and statistical design to detect sex differences in clinical trials.
    Keitt SK; Wagner CR; Tong C; Marts SA
    MedGenMed; 2003 Jun; 5(2):39. PubMed ID: 14603138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An alternative approach to assess exchangeability of a test treatment and the standard treatment with normally distributed response.
    Tsong Y; Shen M
    J Biopharm Stat; 2007; 17(2):329-38. PubMed ID: 17365227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.